about
Intracellular detection and evolution of site-specific proteases using a genetic selection systemIntra-cellular Staphylococcus aureus alone causes infection in vivoDifferential responses of osteoblasts and macrophages upon Staphylococcus aureus infectionAntibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B.Laser desorption postionization mass spectrometry of antibiotic-treated bacterial biofilms using tunable vacuum ultraviolet radiation.Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibioticsRecombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumoniaAntistaphylococcal activity of bacteriophage derived chimeric protein P128EnzyBase: a novel database for enzybiotic studies.Anti-staphylococcal activities of lysostaphin and LytM catalytic domainEfficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection.Potential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation.Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse modelInhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion mediumDetermining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Förster resonance energy transfer (FRET) assaysBeyond growth: novel functions for bacterial cell wall hydrolasesIn Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein.Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic.Extracellular metalloproteases from bacteria.Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms.In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.A review of the recent advances in antimicrobial coatings for urinary catheters.Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus.Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.Orthopedic implant infections: Incompetence of Staphylococcus epidermidis, Staphylococcus lugdunensis, and Enterococcus faecalis to invade osteoblasts.EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.Bacillus subtilis CwlP of the SP-{beta} prophage has two novel peptidoglycan hydrolase domains, muramidase and cross-linkage digesting DD-endopeptidase.Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans.Antibiofilm agents: A new perspective for antimicrobial strategy.Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.Methods to identify enzymes that degrade the main extracellular polysaccharide component of Staphylococcus epidermidis biofilms.Characterization of the staphylococcal bacteriophage lysin CHAP(K).1H, 13C and 15N resonance assignments of the new lysostaphin family endopeptidase catalytic domain from Staphylococcus aureus.In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus.Sodium Polyanethol Sulfonate Modulates Natural Transformation of SigH-Expressing Staphylococcus aureus.Clostridium difficile secreted Pro-Pro endopeptidase PPEP-1 (ZMP1/CD2830) modulates adhesion through cleavage of the collagen binding protein CD2831.
P2860
Q28257999-AA61C9DC-4924-4815-B737-2DC2EBA6AB71Q28391136-8410219F-CA93-48A5-93F3-6FC51814C5AEQ28391444-F059B0A7-84E9-43C0-9BA4-09D0D11B2EE8Q33579524-CFC08A53-0850-4AAE-BC02-FE744CAE3029Q33659336-541C77A5-D618-4013-8E95-8EAAD0E45AF1Q33664443-6A4FA4E2-5B4D-4386-A896-F284AAC9C741Q33798586-4FA1F053-31FB-4AF5-A87D-0678E774E2EBQ34012319-25E7E7EC-2845-4FE4-85A0-FA9CB6494395Q34206850-2D4E51B6-A3BC-435B-985C-DED489757A1EQ34226868-C1E41648-14BF-4D98-9F0D-E174DBA80268Q34294373-C47D6756-E391-4FBA-AFCB-3604C0C235F2Q34394175-A093DF7B-B289-4829-B25E-9FD2343B3812Q34566563-71A35B3D-6C51-4F1C-A619-3B35B23C7AA9Q34764770-E96417E0-A050-467F-BBBB-8015A0FCA223Q35599270-1079F769-A6D4-4A30-A210-A1CAA4DB4E5EQ36309151-602A05A1-EC7C-468B-B076-CB9881818C9BQ36342088-52BA6738-F11A-4D29-8216-B6F07DD19614Q36911438-87143693-2ACA-4D97-B38D-7A4A828440B1Q36994350-44D84020-5C84-45EE-BBC8-B64032474951Q37755985-58D273F0-3B9E-4B14-8AF1-2A222712C52EQ37918447-6598495D-5967-4850-B8CE-3B71E1D07AF1Q38071062-492CD80F-45B6-4D67-B037-D41AA0E1D299Q38282871-BD55A856-C1ED-4A95-BB35-0E3726F0597FQ38702083-78702D94-4F28-48AA-BDD2-C2A5677767B2Q38787366-EC5E75DC-08E1-4A57-A018-7053EA6D9A4DQ38998331-B2F4AC84-1B09-4EED-8CAD-355D818356C1Q39174819-D863FEDE-9CCE-4A4F-92E3-B86F64C873D0Q39766508-8F871A61-5887-4325-9CE1-2729D47354BDQ40995303-DDE4AEB6-822D-4D79-8F2B-206A22C1B622Q41457130-ED7A8755-0DAA-4F26-9323-E3FCF6031E89Q41465809-61DB9AA7-64B0-4244-85CE-ED0A1D13D618Q41831638-E57DB7CC-2AFB-499E-AC24-6B45920B013DQ41993542-D4D456D9-713A-4DCC-B2F5-DC29F9A2F968Q42411103-C0D9CA90-0582-4C83-95C0-7DFB56F1DCB6Q43091002-F3EF4872-9DE4-48E9-B640-87E11A867ED6Q44488180-5F11E0DB-F240-438D-BD55-83DC889C3A89Q46447298-4B51FDC7-C0E7-41C8-8E6C-5D93A898C197Q47096972-5A82A9C2-8841-4C2C-ACFF-3142E4B7449BQ48171161-C7E8D834-40EF-439D-89EA-52A1363A3C05Q51740491-0729DFBE-D1D3-478E-8C14-BFC8C80FC60B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lysostaphin: an antistaphylococcal agent.
@en
Lysostaphin: an antistaphylococcal agent.
@nl
type
label
Lysostaphin: an antistaphylococcal agent.
@en
Lysostaphin: an antistaphylococcal agent.
@nl
prefLabel
Lysostaphin: an antistaphylococcal agent.
@en
Lysostaphin: an antistaphylococcal agent.
@nl
P1476
Lysostaphin: an antistaphylococcal agent.
@en
P2093
Jaspal K Kumar
P2860
P2888
P304
P356
10.1007/S00253-008-1579-Y
P407
P577
2008-07-08T00:00:00Z